Turtle Creek Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Turtle Creek Wealth Advisors's PFE Position: Q3 2026 in Review
Turtle Creek Wealth Advisors increased its Pfizer (PFE) stake by 6.1% in Q3 2026, buying an estimated $59.7K and bringing the position to 39,116 shares worth $1.12M. The position accounts for 0.06% of the portfolio, ranked #162.
Turtle Creek Wealth Advisors first reported a position in PFE in Q4 2023 and has held it in 9 quarters since. 2,640 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Turtle Creek Wealth Advisors held 39,116 shares of Pfizer worth $1.12M as of Q3 2026.
- Turtle Creek Wealth Advisors bought 2,246 Pfizer shares in Q3 2026, an estimated $59.7K.
- Pfizer made up 0.06% of Turtle Creek Wealth Advisors's portfolio in Q3 2026, its #162 holding.
- Turtle Creek Wealth Advisors first reported a position in Pfizer in Q4 2023 and has held it in 9 quarters since.
- 2,640 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.